AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2014
Dec 8, 2014
284_dirs_2014-12-08_68c24a30-722c-4b75-ab53-59d685f54a6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-12-08
Reporting Person: Kuhlik Bruce N (Exe V-P & Gen Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-08 | Common Stock | M | 50000.0000 | $51.0200 | Acquired | 178467.4960 | Direct |
| 2014-12-08 | Common Stock | S | 50000.0000 | $62.0000 | Disposed | 128467.4960 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-08 | Stock Option (right to buy) | $51.0200 | M | 50000.0000 | Disposed | 2017-07-31 | Common Stock (50000.0000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: Holdings include shares acquired in dividend reinvestment transactions.
F3: The option became exercisable in equal installments on 8/1/2008, 8/1/2009 and 8/1/2010.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8